Literature DB >> 35834005

Renal manifestations in inflammatory bowel disease: a systematic review.

Karen van Hoeve1, Ilse Hoffman2.   

Abstract

As extra-intestinal manifestations (EIMs) are frequent in inflammatory bowel disease (IBD) and affect morbidity and sometimes even mortality, vigilance in the surveillance of EIMs and installing the appropriate treatment are essential. Data on renal manifestations in patients with IBD are however rare. Nevertheless, up to 5-15% of adult patients with IBD will develop chronic kidney disease over time. The pathophysiology of renal involvement in patients with IBD is complex and poorly understood, with a wide range of renal disorders affecting the glomeruli and/or the tubular structure. Furthermore, medication used to treat IBD can be potentially nephrotoxic and metabolic complication due to the disease itself can furthermore cause renal damage. The aim of this systematic review is to provide an overview of the existing data in literature on these renal manifestations and complications in patients with IBD.
© 2022. Japanese Society of Gastroenterology.

Entities:  

Keywords:  Inflammatory bowel disease; Kidney; Renal manifestation

Mesh:

Year:  2022        PMID: 35834005     DOI: 10.1007/s00535-022-01903-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   6.772


  89 in total

1.  Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.

Authors:  Stephan R Vavricka; Lionel Brun; Pierluigi Ballabeni; Valérie Pittet; Bettina Mareike Prinz Vavricka; Jonas Zeitz; Gerhard Rogler; Alain M Schoepfer
Journal:  Am J Gastroenterol       Date:  2010-08-31       Impact factor: 10.864

2.  The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Marcus Harbord; Vito Annese; Stephan R Vavricka; Matthieu Allez; Manuel Barreiro-de Acosta; Kirsten Muri Boberg; Johan Burisch; Martine De Vos; Anne-Marie De Vries; Andrew D Dick; Pascal Juillerat; Tom H Karlsen; Ioannis Koutroubakis; Peter L Lakatos; Tim Orchard; Pavol Papay; Tim Raine; Max Reinshagen; Diamant Thaci; Herbert Tilg; Franck Carbonnel
Journal:  J Crohns Colitis       Date:  2015-11-27       Impact factor: 9.071

3.  The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.

Authors:  C R H Hedin; S R Vavricka; A J Stagg; A Schoepfer; T Raine; L Puig; U Pleyer; A Navarini; A E van der Meulen-de Jong; J Maul; K Katsanos; A Kagramanova; T Greuter; Y González-Lama; F van Gaalen; P Ellul; J Burisch; D Bettenworth; M D Becker; G Bamias; F Rieder
Journal:  J Crohns Colitis       Date:  2019-04-26       Impact factor: 9.071

4.  ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications.

Authors:  Christian Maaser; Andreas Sturm; Stephan R Vavricka; Torsten Kucharzik; Gionata Fiorino; Vito Annese; Emma Calabrese; Daniel C Baumgart; Dominik Bettenworth; Paula Borralho Nunes; Johan Burisch; Fabiana Castiglione; Rami Eliakim; Pierre Ellul; Yago González-Lama; Hannah Gordon; Steve Halligan; Konstantinos Katsanos; Uri Kopylov; Paulo G Kotze; Eduards Krustinš; Andrea Laghi; Jimmy K Limdi; Florian Rieder; Jordi Rimola; Stuart A Taylor; Damian Tolan; Patrick van Rheenen; Bram Verstockt; Jaap Stoker
Journal:  J Crohns Colitis       Date:  2019-02-01       Impact factor: 9.071

Review 5.  Extraintestinal manifestations and complications in inflammatory bowel diseases.

Authors:  Katja S Rothfuss; Eduard F Stange; Klaus R Herrlinger
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 6.  Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis.

Authors:  Thomas Greuter; Stephan R Vavricka
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2019-02-20       Impact factor: 3.869

7.  Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.

Authors:  Thomas Greuter; Fabio Bertoldo; Roman Rechner; Alex Straumann; Luc Biedermann; Jonas Zeitz; Benjamin Misselwitz; Michael Scharl; Gerhard Rogler; Ekaterina Safroneeva; Raja A R Ali; Christian Braegger; Klaas Heyland; Pascal Mueller; Andreas Nydegger; Laetitia-Marie Petit; Susanne Schibli; Raoul I Furlano; Johannes Spalinger; Michela Schäppi; Samuel Zamora; Florian Froehlich; Denise Herzog; Alain M Schoepfer; Stephan R Vavricka
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-08       Impact factor: 2.839

8.  Extracolonic diagnoses in ulcerative colitis: an epidemiological study.

Authors:  U Monsén; J Sorstad; G Hellers; C Johansson
Journal:  Am J Gastroenterol       Date:  1990-06       Impact factor: 10.864

9.  Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease.

Authors:  Folashade Adebisi Jose; Elizabeth A Garnett; Eric Vittinghoff; George D Ferry; Harland S Winter; Robert N Baldassano; Barbara S Kirschner; Stanley A Cohen; Benjamin D Gold; Oren Abramson; Melvin B Heyman
Journal:  Inflamm Bowel Dis       Date:  2009-01       Impact factor: 5.325

Review 10.  Extraintestinal manifestations and complications in inflammatory bowel disease: from shared genetics to shared biological pathways.

Authors:  Suzanne van Sommeren; Marcel Janse; Juha Karjalainen; Rudolf Fehrmann; Lude Franke; Jingyuan Fu; Rinse K Weersma
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.